Stacey Gross, NP

NPI: 1760720221
Total Payments
$13,896
2024 Payments
$351.36
Companies
15
Transactions
51
Medicare Patients
2,646
Medicare Billing
$260,301

Payment Breakdown by Category

Consulting$5,944 (42.8%)
Other$3,900 (28.1%)
Travel$2,586 (18.6%)
Food & Beverage$1,466 (10.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $5,944 8 42.8%
Honoraria $3,900 3 28.1%
Travel and Lodging $2,586 4 18.6%
Food and Beverage $1,466 36 10.5%

Top Paying Companies

Company Total Records Latest Year
Impulse Dynamics (USA) Inc. $7,917 12 $0 (2023)
Edwards Lifesciences Corporation $5,044 9 $0 (2023)
Amgen Inc. $155.35 7 $0 (2024)
Lexicon Pharmaceuticals, Inc. $150.42 2 $0 (2024)
Janssen Pharmaceuticals, Inc $142.60 5 $0 (2024)
Novartis Pharmaceuticals Corporation $103.79 4 $0 (2024)
PFIZER INC. $86.59 3 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $67.33 2 $0 (2024)
E.R. Squibb & Sons, L.L.C. $66.65 1 $0 (2022)
Kiniksa Pharmaceuticals International, plc $44.35 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $351.36 10 Lexicon Pharmaceuticals, Inc. ($120.54)
2023 $1,699 12 Impulse Dynamics (USA) Inc. ($1,045)
2022 $10,776 24 Impulse Dynamics (USA) Inc. ($5,872)
2021 $1,069 5 Impulse Dynamics (USA) Inc. ($1,000)

All Payment Transactions

51 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/10/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $28.18 General
Category: Cardiology
08/27/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $26.83 General
Category: Cardiovascular & Metabolism
07/29/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $44.35 General
Category: Not Applicable
07/18/2024 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $120.54 General
Category: Inhibitor of SGLT2 and SGLT1
06/25/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $24.93 General
Category: Diabetes
03/04/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $21.71 General
Category: DIABETES
02/29/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $28.47 General
Category: Cardiology/Vascular Diseases
02/27/2024 AstraZeneca Pharmaceuticals LP WAINUA (Drug) Food and Beverage In-kind items and services $13.41 General
Category: Cardiovascular and Metabolism
02/06/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $22.91 General
Category: Cardiology/Vascular Diseases
01/09/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $20.03 General
Category: Cardiology/Vascular Diseases
12/13/2023 Lexicon Pharmaceuticals, Inc. Inpefa (Drug) Food and Beverage In-kind items and services $29.88 General
Category: Inhibitor of SGLT2 and SGLT1
12/05/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $19.57 General
Category: Cardiology
11/21/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $32.38 General
Category: Cardiology/Vascular Diseases
11/09/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID Food and Beverage In-kind items and services $22.31 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/06/2023 PFIZER INC. VYNDAMAX (Drug) Food and Beverage In-kind items and services $43.00 General
Category: CARDIOVASCULAR
06/29/2023 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $23.82 General
Category: Cardiology
06/20/2023 Edwards Lifesciences Corporation Consulting Fee Cash or cash equivalent $363.00 General
06/06/2023 PFIZER INC. ELIQUIS (Drug), COMIRNATY Food and Beverage In-kind items and services $21.28 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
05/23/2023 Edwards Lifesciences Corporation Food and Beverage In-kind items and services $43.36 General
02/23/2023 Boston Scientific Corporation EkoSonic (Device) Food and Beverage In-kind items and services $35.23 General
Category: EkoSonic_PI
01/30/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Travel and Lodging Cash or cash equivalent $1,044.80 General
Category: Cardiovascular Device
01/13/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.82 General
Category: Cardiovascular & Metabolism
12/09/2022 Impulse Dynamics (USA) Inc. Optimizer (Device) Honoraria Cash or cash equivalent $1,200.00 General
Category: Cardiovascular
12/01/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $23.76 General
Category: Cardiology
10/28/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.82 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 790 1,112 $420,773 $91,166
2022 10 713 1,019 $347,353 $74,545
2021 14 677 1,024 $285,852 $64,862
2020 11 466 626 $134,095 $29,728
Total Patients
2,646
Total Services
3,781
Medicare Billing
$260,301
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 280 380 $225,856 $47,853 21.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 76 218 $78,014 $18,903 24.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 101 119 $50,541 $10,763 21.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 50 57 $35,493 $6,919 19.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 43 $10,022 $2,480 24.7%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 18 21 $8,937 $1,734 19.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 119 129 $9,568 $1,296 13.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 120 145 $2,342 $1,218 52.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 168 203 $121,597 $26,376 21.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 96 270 $89,098 $20,058 22.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 129 176 $75,604 $15,342 20.3%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 44 49 $21,274 $4,790 22.5%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 29 39 $16,743 $3,664 21.9%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 23 24 $7,724 $1,606 20.8%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 14 14 $4,264 $757.39 17.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 13 14 $4,249 $753.09 17.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 74 78 $5,432 $748.15 13.8%
36415 Insertion of needle into vein for collection of blood sample Office 2022 123 152 $1,368 $449.79 32.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 184 278 $110,910 $25,369 22.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 107 254 $59,414 $13,255 22.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 64 125 $41,807 $9,338 22.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 26 26 $14,215 $3,239 22.8%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 22 26 $14,230 $3,214 22.6%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 36 38 $12,497 $2,716 21.7%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 20 22 $9,724 $2,197 22.6%

About Stacey Gross, NP

Stacey Gross, NP is a Nurse Practitioner healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760720221.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Gross, NP has received a total of $13,896 in payments from pharmaceutical and medical device companies, with $351.36 received in 2024. These payments were reported across 51 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($5,944).

As a Medicare-enrolled provider, Gross has provided services to 2,646 Medicare beneficiaries, totaling 3,781 services with total Medicare billing of $260,301. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Adult Health, Acute Care
  • Location Los Angeles, CA
  • Active Since 01/17/2013
  • Last Updated 06/28/2023
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1760720221

Products in Payments

  • Optimizer (Device) $5,872
  • OPTIMIZER (Device) $1,045
  • Optimizer Smart System (Device) $1,000
  • Inpefa (Drug) $150.42
  • XARELTO (Drug) $142.60
  • Repatha (Biological) $111.26
  • JARDIANCE (Drug) $67.33
  • CAMZYOS (Drug) $66.65
  • ENTRESTO (Drug) $52.41
  • LEQVIO (Drug) $51.38
  • Arcalyst (Drug) $44.35
  • Corlanor (Drug) $44.09
  • ELIQUIS (Drug) $43.59
  • VYNDAMAX (Drug) $43.00
  • EkoSonic (Device) $35.23
  • Ozempic (Drug) $24.93
  • Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $24.54
  • FUROSCIX (Drug) $23.82
  • OPSUMIT (Drug) $20.41
  • WAINUA (Drug) $13.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Los Angeles